Thus, the aim of this study was to investigate the relationship among nervous system biomarkers (NfL, TAU, GFAP, and UCH-L1), biochemical parameters, viral loads, and heterogeneous outcomes in a cohort of severe COVID-19 patients at admission in the ICU of a public hospital. This evidence concerns the gene GFAP and COVID-19.